HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$2.09
Day range
$2.03 - $2.16
Year range
$1.78 - $39.30
Market cap
3.49M USD
Avg Volume
78.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.33M | 90.91% |
Net income | -2.20M | -82.42% |
Net profit margin | — | — |
Earnings per share | -35.72 | 46.85% |
EBITDA | -2.32M | -91.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.99M | 128.28% |
Total assets | 12.21M | 121.91% |
Total liabilities | 5.56M | 25.03% |
Total equity | 6.65M | — |
Shares outstanding | 1.63M | — |
Price to book | 0.08 | — |
Return on assets | -44.00% | — |
Return on capital | -75.19% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.20M | -82.42% |
Cash from operations | -2.00M | -111.39% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.00M | -112.51% |
Free cash flow | -1.25M | -152.57% |
About
Founded
2019
Website
Employees
9